Cite
HARVARD Citation
Bokemeyer, B. et al. (n.d.). P590 An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab. Journal of Crohn's and colitis. p. S410. [Online].